Search results
MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution...
WFRV 5 Green Bay· 2 days agoMemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County – and one of only two in California – to offer a new, innovative way to treat ...
Could cannabis treat cancer someday? Here's what the science says so far
Live Science via Yahoo News· 2 days agoThere are several ways in which cannabinoids have been...said. For example, in rodent studies,...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 6 days agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May ...
Health Benefits of Rambutan
Health via Yahoo News· 15 hours agoRambutans are unique-looking fruits with a sweet, slightly acidic taste and a grape-like texture. They're rich in antioxidants and support digestive...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 6 days agoNovartis’ success with Pluvicto in prostate cancer has motivated others, Mariana among them, to follow into the field. “We...combine an isotope, like...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 7 days agoThe drugs’ overall success has sparked significant interest from...pharma agrees...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
The Daily News· 18 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
Denton Record-Chronicle· 6 days ago"The high complete response rate and durability of these responses observed in patients treated with TAR-200 underscores the potential of this treatment approach for patients...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 2 days ago...dose escalation and targeting development of joint Amgen / IDEAYA publication strategy in 2024First-patient-in (FPI) for Phase 1 trial of IDE397 in combination with Gilead's Trodelvy® in MTAP bladder cancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors...
